Product Portfolio

Our approach is to achieve balance in the products that we develop through a portfolio comprised of innovative vaccines and therapeutics that target infectious diseases worldwide.

BioThrax® (Anthrax Vaccine Adsorbed)

Anthrax IG Therapeutic

Typhoid Vaccine

Hepatitis B Therapeutic

Recombinant Protective Antigen Vaccine

Tuberculosis Vaccine

Group B Streptococcus Vaccine

Botulinum Vaccines

Chlamydia Vaccine

Meningitis B Vaccine

ALL INVESTIGATIONAL PRODUCTS MUST SUCCESSFULLY COMPLETE THEIR RESPECTIVE DEVELOPMENT PROGRAMS AND BE APPROVED BY THE FDA (AND/OR FOREIGN EQUIVALENTS) BEFORE THEY MAY BE MARKETED.